Massimino Kristen P, Jochelson Maxine S, Burgan Imelda E, Stempel Michelle, Morrow Monica
Division of Surgical Oncology, Department of Surgery, Oregon Health & Science University, Portland, OR, USA.
Breast Imaging Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Ann Surg Oncol. 2016 Oct;23(11):3518-3523. doi: 10.1245/s10434-016-5301-5. Epub 2016 Jun 15.
The aim of this study was to determine the rate of non-palpable cancer detection and benign biopsy rates for follow-up mammograms in elderly breast cancer survivors.
Women 80 years of age and older who underwent operation for ductal carcinoma in situ or invasive breast cancer from 2005 to 2010 and who had at least 6 months of follow-up were identified from a single-institution, prospectively maintained, Health Insurance Portability and Accountability Act (HIPAA)-compliant database. Patients with mammographic, other imaging, or palpable abnormalities were identified, and the results of their imaging studies and biopsies were reviewed. Number of locoregional recurrences, contralateral cancers, and benign biopsies were determined. Follow-up and survival data were recorded.
Overall, 429 women with a mean age of 83.4 years were included. Mean follow-up was 50.0 months (range 6-113). Patients had a median of four follow-up mammograms (range 0-11). The 1466 mammograms detected 17 biopsy-proven cancers and generated 18 benign biopsies. In the 305 women who had had breast-conserving surgery, 18 (5.9 %) experienced local recurrence, 9 detected by mammography alone (mean size 1.2 cm) and 9 palpable (mean size 2.0 cm). Contralateral cancer developed in 4 (0.9 %) of the 429 patients, all detected on screening mammogram alone.
Overall, 13 non-palpable breast cancers were detected in 1466 mammograms (0.9 %). While these results are acceptable for screening programs in healthy populations, further study of the need for routine follow-up imaging in the elderly, and the appropriate interval, is needed to maximize resource utilization.
本研究旨在确定老年乳腺癌幸存者随访乳房X光检查中不可触及癌症的检出率和良性活检率。
从一个单一机构前瞻性维护的、符合《健康保险流通与责任法案》(HIPAA)的数据库中,识别出2005年至2010年期间接受原位导管癌或浸润性乳腺癌手术且至少随访6个月的80岁及以上女性。识别出有乳房X光检查、其他影像学检查或可触及异常的患者,并回顾其影像学检查和活检结果。确定局部复发、对侧癌症和良性活检的数量。记录随访和生存数据。
总体而言,纳入了429名平均年龄为83.4岁的女性。平均随访时间为50.0个月(范围6 - 113个月)。患者的乳房X光检查中位次数为4次(范围0 - 11次)。1466次乳房X光检查发现了17例经活检证实的癌症,并进行了18次良性活检。在305名接受保乳手术的女性中,18例(5.9%)出现局部复发,9例仅通过乳房X光检查发现(平均大小1.2厘米),9例可触及(平均大小2.0厘米)。429例患者中有4例(0.9%)发生对侧癌症,均仅在筛查乳房X光检查时发现。
总体而言,在1466次乳房X光检查中发现了13例不可触及的乳腺癌(0.9%)。虽然这些结果对于健康人群的筛查项目来说是可以接受的,但需要进一步研究老年人常规随访影像学检查的必要性以及合适的间隔时间,以最大限度地利用资源。